Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04090528
Title pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

prostate adenocarcinoma

Therapies

Pembrolizumab + pTVG-AR + pTVG-HP plasmid DNA vaccine + Sargramostim

Pembrolizumab + pTVG-HP plasmid DNA vaccine + Sargramostim

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.